156 related articles for article (PubMed ID: 27610157)
1. Design, Synthesis and Biological Evaluation of4-(Imidazolylmethyl)-2-(4-methylsulfonyl phenyl)-Quinoline Derivatives as Selective COX-2 Inhibitors and In-vitro Anti-breast Cancer Agents.
Ghodsi R; Azizi E; Zarghi A
Iran J Pharm Res; 2016; 15(1):169-77. PubMed ID: 27610157
[TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of New 2-Phenyl-4H-chromen-4-one Derivatives as Selective Cyclooxygenase-2 Inhibitors.
Zarghi A; Kakhki S
Sci Pharm; 2015; 83(1):15-26. PubMed ID: 26839798
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors.
Bayanati M; Daraei B; Zarghi A
Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 5-oxo-1,4,5,6,7,8 hexahydroquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Zarghi A; Sabakhi I; Topuzyan V; Hajimahdi Z; Daraie B
Iran J Pharm Res; 2014; 13(Suppl):61-9. PubMed ID: 24711830
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new pyrazino[1,2-a]benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors.
Azami Movahed M; Daraei B; Shahosseini S; Esfahanizadeh M; Zarghi A
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800265. PubMed ID: 30561073
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of new 5,5-diarylhydantoin derivatives as selective cyclooxygenase-2 inhibitors.
Zarghi A; Javid FS; Ghodsi R; Dadrass OG; Daraei B; Hedayati M
Sci Pharm; 2011; 79(3):449-60. PubMed ID: 21886896
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
[TBL] [Abstract][Full Text] [Related]
11. Novel Benzo[4,5]imidazo[1,2-
Bayanati M; Khoramjouy M; Faizi M; Movahed MA; Mahboubi-Rabbani M; Zarghi A
Med Chem Res; 2023; 32(3):495-505. PubMed ID: 36713891
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Biological Evaluation of New Imidazo[2,1-b]Thiazole Derivatives as Selective COX-2 Inhibitors.
Shahrasbi M; Azami Movahed M; Ghorban Dadras O; Daraei B; Zarghi A
Iran J Pharm Res; 2018; 17(4):1288-1296. PubMed ID: 30568687
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-
Movahed MA; Abbasi FK; Rajabi M; Abedi N; Naderi N; Daraei B; Zarghi A
Med Chem Res; 2023; 32(5):856-868. PubMed ID: 37056461
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 2-(4-methylsulfonyl phenyl) indole derivatives: multi-target compounds with dual antimicrobial and anti-inflammatory activities.
Shaker AMM; Abdelall EKA; Abdellatif KRA; Abdel-Rahman HM
BMC Chem; 2020 Dec; 14(1):23. PubMed ID: 32259135
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cyclooxygenase inhibitory activities of linear 1-(methanesulfonylphenyl or benzenesulfonamido)-2-(pyridyl)acetylene regioisomers.
Chowdhury MA; Dong Y; Chen QH; Abdellatif KR; Knaus EE
Bioorg Med Chem; 2008 Feb; 16(4):1948-56. PubMed ID: 18023187
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors.
Ahmaditaba MA; Shahosseini S; Daraei B; Zarghi A; Houshdar Tehrani MH
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28872704
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors.
Sabakhi I; Topuzyan V; Hajimahdi Z; Daraei B; Arefi H; Zarghi A
Iran J Pharm Res; 2015; 14(4):1087-93. PubMed ID: 26664375
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of new (E)- and (Z)-1,2,3-triaryl-2-propen-1-ones as selective COX-2 inhibitors.
Arfaie S; Zarghi A
Eur J Med Chem; 2010 Sep; 45(9):4013-7. PubMed ID: 20691338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]